Mystic Asset Management Inc. Invests $340,000 in Agilent Technologies, Inc. (NYSE:A)

Mystic Asset Management Inc. acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,531 shares of the medical research company's stock, valued at approximately $340,000.

Other large investors also recently added to or reduced their stakes in the company. Madison Investment Advisors LLC acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at about $94,051,000. Massachusetts Financial Services Co. MA raised its position in shares of Agilent Technologies by 3.5% in the third quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company's stock valued at $2,314,784,000 after buying an additional 525,214 shares during the last quarter. FMR LLC raised its position in shares of Agilent Technologies by 62.2% in the third quarter. FMR LLC now owns 1,287,665 shares of the medical research company's stock valued at $191,193,000 after buying an additional 493,947 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at about $48,172,000. Finally, Worldquant Millennium Advisors LLC acquired a new stake in Agilent Technologies during the third quarter worth about $49,449,000.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the company's stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares of the company's stock, valued at approximately $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of the company's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now directly owns 21,786 shares of the company's stock, valued at $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Remove Ads

Agilent Technologies Stock Up 0.4 %

Shares of A stock traded up $0.44 on Friday, reaching $120.72. 3,041,425 shares of the stock were exchanged, compared to its average volume of 1,682,117. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56. The business's 50 day moving average price is $136.74 and its 200 day moving average price is $137.30. The company has a market capitalization of $34.42 billion, a price-to-earnings ratio of 27.75, a PEG ratio of 3.38 and a beta of 1.11. Agilent Technologies, Inc. has a twelve month low of $117.17 and a twelve month high of $155.35.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The firm had revenue of $1.68 billion during the quarter, compared to analysts' expectations of $1.67 billion. As a group, sell-side analysts expect that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be given a $0.248 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.82%. Agilent Technologies's dividend payout ratio (DPR) is presently 22.76%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on A shares. Robert W. Baird cut their price objective on shares of Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a research report on Thursday, February 27th. JPMorgan Chase & Co. cut their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research report on Tuesday, November 26th. Citigroup raised their price objective on shares of Agilent Technologies to $165.00 and gave the stock a "buy" rating in a research report on Thursday, December 19th. StockNews.com upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Tuesday, December 24th. Finally, Wells Fargo & Company cut their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating for the company in a research report on Monday, December 9th. Seven equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $146.15.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.